Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Stomach Neoplasms 1 Mesothelioma, Malignant 1 Gastrointestinal Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Adenocarcinoma Of Esophagus 1 Adenocarcinoma 1

Interventions

Cisplatin 4 tremelimumab 3 Pemetrexed 3 durvalumab 2 atezolizumab 2 Radiotherapy 2 Nivolumab 2 Mitomycin 2 Doxorubicin 2 toripalimab 1 talazoparib 1 rucaparib 1 regorafenib 1 ranpirnase 1 pembrolizumab 1 niraparib 1 liposomal doxorubicin 1 dostarlimab 1 cemiplimab 1 bemcentinib 1 avelumab 1 abemaciclib 1 Vinorelbine 1 Vinblastine 1 Thiostrepton 1 Surgical Procedures, Operative 1 Oxaliplatin 1 One-Lung Ventilation 1 Neoadjuvant Therapy 1 Megestrol Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Mesothelioma, Malignant × rucaparib × Clear all

NCT03654833 2023-03-14

MiST

University of Leicester

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡